Previous close | 12.59 |
Open | 12.58 |
Bid | 12.25 x 100 |
Ask | 12.33 x 100 |
Day's range | 12.15 - 12.58 |
52-week range | 7.31 - 16.48 |
Volume | |
Avg. volume | 91,814 |
Market cap | 183.41M |
Beta (5Y monthly) | 1.58 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.66 |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 12.19 |
SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results. Shareholders and interested participants may listen to a live broadcast o
The Joint Chiropractic, the nation's largest provider of chiropractic care through The Joint Chiropractic® network, is proud to announce a year-long sponsorship of Rachel's Challenge, a non-profit organization for school violence prevention. The Joint is honored to be joining Rachel's Challenge in its vision to create schools full of hope, free from harassment, violence, and self-harm, where teachers are free to teach and students are inspired to learn.
Logan University and The Joint Corp. are proud to establish The Joint Chiropractic Endowed Scholarship for Logan's Doctor of Chiropractic students. This scholarship is aimed at supporting and empowering Logan's exceptional students in their pursuit of higher education. The Joint Corp. is the nation's largest provider of chiropractic care through The Joint Chiropractic® network.